The stock price of Agilon Health Inc (NYSE: AGL) has surged by 1.49 when compared to previous closing price of 5.38, but the company has seen a 10.30% gain in its stock price over the last five trading sessions. Business Wire reported 2024-04-16 that AUSTIN, Texas–(BUSINESS WIRE)–agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2024 after the market closes on Tuesday, May 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for international partic.
Is It Worth Investing in Agilon Health Inc (NYSE: AGL) Right Now?
Company’s 36-month beta value is 0.54.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AGL is 301.79M, and currently, short sellers hold a 15.58% ratio of that floaft. The average trading volume of AGL on April 22, 2024 was 5.30M shares.
AGL’s Market Performance
AGL’s stock has seen a 10.30% increase for the week, with a -0.91% drop in the past month and a -14.29% fall in the past quarter. The volatility ratio for the week is 11.31%, and the volatility levels for the past 30 days are at 9.19% for Agilon Health Inc The simple moving average for the last 20 days is 6.11% for AGL stock, with a simple moving average of -56.50% for the last 200 days.
Analysts’ Opinion of AGL
Many brokerage firms have already submitted their reports for AGL stocks, with Barclays repeating the rating for AGL by listing it as a “Underweight.” The predicted price for AGL in the upcoming period, according to Barclays is $5 based on the research report published on March 06, 2024 of the current year 2024.
TD Cowen, on the other hand, stated in their research note that they expect to see AGL reach a price target of $6.50, previously predicting the price at $12. The rating they have provided for AGL stocks is “Market Perform” according to the report published on February 26th, 2024.
Jefferies gave a rating of “Hold” to AGL, setting the target price at $6.50 in the report published on February 26th of the current year.
AGL Trading at -5.78% from the 50-Day Moving Average
After a stumble in the market that brought AGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.76% of loss for the given period.
Volatility was left at 9.19%, however, over the last 30 days, the volatility rate increased by 11.31%, as shares surge +0.55% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.64% lower at present.
During the last 5 trading sessions, AGL rose by +10.30%, which changed the moving average for the period of 200-days by -68.37% in comparison to the 20-day moving average, which settled at $5.15. In addition, Agilon Health Inc saw -56.49% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGL starting from Schwaneke Jeffrey A., who purchase 22,300 shares at the price of $11.22 back on Nov 29 ’23. After this action, Schwaneke Jeffrey A. now owns 31,931 shares of Agilon Health Inc, valued at $250,206 using the latest closing price.
Shaker Benjamin, the Chief Markets Officer of Agilon Health Inc, sale 18,750 shares at $18.00 during a trade that took place back on Sep 13 ’23, which means that Shaker Benjamin is holding 79,543 shares at $337,455 based on the most recent closing price.
Stock Fundamentals for AGL
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.01 for the gross margin
The net margin for Agilon Health Inc stands at -0.05. The total capital return value is set at -0.3. Equity return is now at value -23.40, with -11.59 for asset returns.
Based on Agilon Health Inc (AGL), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -3.77. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is -33.58.
Currently, EBITDA for the company is -211.78 million with net debt to EBITDA at 0.36. When we switch over and look at the enterprise to sales, we see a ratio of 0.48. The receivables turnover for the company is 4.84for trailing twelve months and the total asset turnover is 2.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.51.
Conclusion
In a nutshell, Agilon Health Inc (AGL) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
